electroCore, Inc. Common Stock
ECOR Real Time Price USDRecent trades of ECOR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ECOR's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
ECOR Revenue by Segment or Geography
No Revenue by Segment data for this ticker
No Revenue by Geography data for this ticker
New patents grants
-
Patent Title: Devices and methods for non-invasive vagal nerve stimulation Jan. 28, 2025
-
Patent Title: Devices and methods for non-invasive nerve stimulation Dec. 31, 2024
-
Patent Title: Systems and methods for initial provisioning and refilling of medical devices Dec. 24, 2024
-
Patent Title: Non-invasive electrical stimulation for medical disorders Dec. 24, 2024
-
Patent Title: Systems and methods for treating a medical condition Dec. 17, 2024
-
Patent Title: Devices and methods for treating or preventing development disorders Dec. 17, 2024
-
Patent Title: Vagal nerve stimulation for treating dopamine-related conditions Aug. 27, 2024
-
Patent Title: Devices and methods for determining the effectiveness of electrical stimulation Aug. 06, 2024
-
Patent Title: Non-invasive nerve stimulation with mobile device Apr. 02, 2024
-
Patent Title: Vagal nerve stimulation for treating central nervous system disorders Apr. 02, 2024
-
Patent Title: Vagal nerve stimulation for treating post-traumatic stress disorder Jan. 09, 2024
-
Patent Title: Medical devices for treating medical conditions Dec. 26, 2023
-
Patent Title: Devices and methods for remote therapy and patient monitoring Dec. 26, 2023
-
Patent Title: Systems and methods for treating a medical condition with an electrical stimulation treatment regimen Dec. 12, 2023
-
Patent Title: Systems and methods for vagal nerve stimulation Oct. 10, 2023
-
Patent Title: Nerve stimulator for use with a mobile device Sep. 26, 2023
-
Patent Title: Non-invasive nerve stimulation with mobile device Jul. 18, 2023
-
Patent Title: Systems and methods for initial provisioning and refilling of medical devices Jun. 27, 2023
-
Patent Title: Stimulator for use with a mobile device Jun. 20, 2023
-
Patent Title: Nerve stimulation devices and methods May. 23, 2023
-
Patent Title: Vagal nerve stimulation for treating dopamine-related conditions Apr. 11, 2023
-
Patent Title: Vagal nerve stimulation devices and methods for treating medical conditions Apr. 11, 2023
-
Patent Title: Devices and methods for non-invasive vagal nerve stimulation Apr. 11, 2023
-
Patent Title: Vagal nerve stimulation therapy Feb. 28, 2023
-
Patent Title: Technologies for initial provisioning and refilling of medical devices Feb. 14, 2023
-
Patent Title: Non-invasive nerve stimulation to treat or prevent autism spectrum disorders and other disorders of psychological development Dec. 27, 2022
-
Patent Title: Non-invasive vagal nerve stimulation to treat disorders Dec. 06, 2022
-
Patent Title: Non-invasive magnetic or electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders Nov. 29, 2022
-
Patent Title: Non-invasive nerve stimulation to patients Oct. 04, 2022
-
Patent Title: Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders Oct. 04, 2022
-
Patent Title: Stimulator for use with a mobile device Sep. 20, 2022
-
Patent Title: Electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders Sep. 13, 2022
-
Patent Title: Devices and methods for remote therapy and patient monitoring Sep. 06, 2022
-
Patent Title: Mobile phone for treating a patient with dementia Aug. 09, 2022
-
Patent Title: Devices and methods for electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Aug. 02, 2022
-
Patent Title: Systems and methods for treating headache with vagal nerve stimulation Jul. 19, 2022
-
Patent Title: Devices and methods for monitoring non-invasive vagus nerve stimulation Jul. 19, 2022
-
Patent Title: Nerve stimulation devices and methods for treating cardiac arrhythmias Jun. 07, 2022
-
Patent Title: Devices and methods for vagal nerve stimulation May. 10, 2022
-
Patent Title: Non-invasive vagus nerve stimulation Apr. 12, 2022
-
Patent Title: Methods and devices for treating primary headache Apr. 05, 2022
-
Patent Title: Nerve stimulator for use with a mobile device Mar. 01, 2022
-
Patent Title: Mobile phone for treating a patient with seizures Jan. 25, 2022
-
Patent Title: Medical self-treatment using non-invasive vagus nerve stimulation Dec. 14, 2021
-
Patent Title: Systems and methods for vagal nerve stimulation Dec. 07, 2021
-
Patent Title: Non-invasive vagus nerve stimulation devices and methods to treat or avert atrial fibrillation Nov. 23, 2021
-
Patent Title: Devices and methods for nerve stimulation Oct. 19, 2021
-
Patent Title: Devices and methods for nerve stimulation Oct. 12, 2021
-
Patent Title: Devices and methods for nerve stimulation Sep. 21, 2021
-
Patent Title: Mobile phone using non-invasive nerve stimulation Aug. 24, 2021
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ECOR
Number of mentions of ECOR in WallStreetBets Daily Discussion
Recent picks made for ECOR stock on CNBC
ETFs with the largest estimated holdings in ECOR
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ECOR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.